Axsome Therapeutics, Inc (AXSM) Financials
Key financial figures for Axsome Therapeutics, Inc (Q1 2026).
- Revenue
- $191M
- Net Income
- -$65M
- EPS
- $-1.26
- Total Assets
- $714M
- Operating Cash Flow
- -$21M
Full income statement, balance sheet, and cash flow for Axsome Therapeutics, Inc on SentiSense.